Abstract:Hutchinson–Gilford progeria is a premature ageing syndrome caused by progerin, a mutant form of lamin A (LA) that harbours a 50 amino acid (50AA) deletion and remains permanently farnesylated. By using a combination of genetic and pharmacological approaches, we demonstrate that the permanent farnesylation (and not the 50AA deletion) causes heterochromatin loss, DNA damage, proliferation defects and premature senescence; and regulates LA turnover. Importantly, early, but not late treatment with farnesyltransferase inhibitors prevent progerin‐induced defects. Hutchinson–Gilford Progeria syndrome (HGPS) is a severe premature ageing disorder caused by a 50 amino acid truncated (Δ50AA) and permanently farnesylated lamin A (LA) mutant called progerin. On a cellular level, progerin expression leads to heterochromatin loss, impaired nucleocytoplasmic transport, telomeric DNA damage and a permanent growth arrest called cellular senescence. Although the genetic basis for HGPS has been elucidated 20 years ago, the question whether the Δ50AA or the permanent farnesylation causes cellular defects has not been addressed. Moreover, we currently lack mechanistic insight into how the only FDA‐approved progeria drug Lonafarnib, a farnesyltransferase inhibitor (FTI), ameliorates HGPS phenotypes. By expressing a variety of LA mutants using a doxycycline‐inducible system, and in conjunction with FTI, we demonstrate that the permanent farnesylation, and not the Δ50AA, is solely responsible for progerin‐induced cellular defects, as well as its rapid accumulation and slow clearance. Importantly, FTI does not affect clearance of progerin post‐farnesylation and we demonstrate that early, but not late FTI treatment prevents HGPS phenotypes. Collectively, our study unravels the precise contributions of progerin's permanent farnesylation to its turnover and HGPS cellular phenotypes, and how FTI treatment ameliorates these. These findings are applicable to other diseases associated with permanently farnesylated proteins, such as adult‐onset autosomal dominant leukodystrophy.

Embryonic expression of the common progeroid lamin A splice mutation arrests postnatal skin development

Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway

Molecular insights into the premature aging disease progeria

The Accumulation of Progerin Underlies the Loss of Aortic Smooth Muscle Cells in Hutchinson-Gilford Progeria Syndrome

A Lamin A Protein Isoform Overexpressed in Hutchinson–Gilford Progeria Syndrome Interferes with Mitosis in Progeria and Normal Cells

Impaired LEF1 Activation Accelerates Ipsc-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome

Correlated Alterations in Genome Organization, Histone Methylation, and DNA–lamin A/C Interactions in Hutchinson-Gilford Progeria Syndrome

Nuclear Localization Signal Deletion Mutants of Lamin A and Progerin Reveal Insights into Lamin A Processing and Emerin Targeting.

Cell autonomous and systemic factors in progeria development

Vascular senescence in progeria: role of endothelial dysfunction

Delayed localization of A-type lamins to the rupture sites in Hutchinson–Gilford progeria syndrome

Title Accumulation of prelamin A compromises NF-kB-regulated B-lymphopoiesis in progeria mouse model

Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis

An Inhibitory Role of Progerin in the Gene Induction Network of Adipocyte Differentiation from Ips Cells

DNA damage responses caused by Zmpste24 deficiency and lamin A mutation in premature ageing

Progerin Expression Induces Inflammation, Oxidative Stress and Senescence in Human Coronary Endothelial Cells

Genetic and pharmacological modulation of lamin A farnesylation determines its function and turnover

Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS)

Accumulation of prelamin A compromises NF-κB-regulated B-lymphopoiesis in a progeria mouse model.

Progerin-Induced Impairment in Wound Healing and Proliferation in Vascular Endothelial Cells

Cell aging caused by prelamin A mutation